Free Trial

Zacks Research Brokers Raise Earnings Estimates for Plexus

Plexus logo with Computer and Technology background

Plexus Corp. (NASDAQ:PLXS - Free Report) - Research analysts at Zacks Research upped their Q1 2026 earnings estimates for Plexus in a report issued on Tuesday, December 24th. Zacks Research analyst V. Doshi now expects that the technology company will post earnings of $1.66 per share for the quarter, up from their previous forecast of $1.62. The consensus estimate for Plexus' current full-year earnings is $6.14 per share. Zacks Research also issued estimates for Plexus' Q2 2026 earnings at $1.62 EPS and Q3 2026 earnings at $1.87 EPS.

Plexus (NASDAQ:PLXS - Get Free Report) last announced its quarterly earnings data on Wednesday, October 23rd. The technology company reported $1.85 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.55 by $0.30. The business had revenue of $1.05 billion during the quarter, compared to the consensus estimate of $1.01 billion. Plexus had a net margin of 2.82% and a return on equity of 9.51%. The firm's quarterly revenue was up 2.6% compared to the same quarter last year. During the same quarter last year, the firm earned $1.44 earnings per share.

PLXS has been the subject of a number of other reports. StockNews.com raised shares of Plexus from a "hold" rating to a "buy" rating in a research note on Monday, November 18th. Stifel Nicolaus upped their target price on shares of Plexus from $136.00 to $150.00 and gave the stock a "hold" rating in a research note on Tuesday, December 10th. Benchmark lifted their price target on shares of Plexus from $150.00 to $165.00 and gave the company a "buy" rating in a research note on Monday, October 28th. KeyCorp initiated coverage on Plexus in a research report on Tuesday, October 22nd. They set a "sector weight" rating for the company. Finally, Needham & Company LLC raised their price target on Plexus from $144.00 to $162.00 and gave the company a "buy" rating in a research note on Friday, October 25th. Three research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $147.25.

View Our Latest Analysis on PLXS

Plexus Trading Down 2.4 %

PLXS traded down $3.86 during trading hours on Friday, reaching $157.79. 90,130 shares of the company's stock traded hands, compared to its average volume of 142,578. The firm has a 50-day moving average price of $157.36 and a 200 day moving average price of $133.18. The firm has a market capitalization of $4.27 billion, a PE ratio of 39.35 and a beta of 0.90. The company has a quick ratio of 0.71, a current ratio of 1.51 and a debt-to-equity ratio of 0.07. Plexus has a 52-week low of $90.18 and a 52-week high of $170.07.

Institutional Investors Weigh In On Plexus

Institutional investors have recently modified their holdings of the business. Disciplined Growth Investors Inc. MN grew its position in shares of Plexus by 0.3% in the second quarter. Disciplined Growth Investors Inc. MN now owns 2,109,047 shares of the technology company's stock valued at $217,611,000 after purchasing an additional 7,245 shares during the period. GSA Capital Partners LLP purchased a new stake in Plexus during the 3rd quarter worth approximately $899,000. Victory Capital Management Inc. raised its holdings in shares of Plexus by 3.9% during the third quarter. Victory Capital Management Inc. now owns 200,186 shares of the technology company's stock valued at $27,367,000 after acquiring an additional 7,483 shares during the last quarter. Schaper Benz & Wise Investment Counsel Inc. WI lifted its position in shares of Plexus by 62.6% in the third quarter. Schaper Benz & Wise Investment Counsel Inc. WI now owns 13,346 shares of the technology company's stock valued at $1,825,000 after acquiring an additional 5,138 shares in the last quarter. Finally, Entropy Technologies LP acquired a new stake in shares of Plexus in the third quarter worth approximately $826,000. 94.45% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Plexus

In related news, COO Oliver K. Mihm sold 5,691 shares of Plexus stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $167.06, for a total transaction of $950,738.46. Following the completion of the transaction, the chief operating officer now directly owns 19,585 shares in the company, valued at approximately $3,271,870.10. This trade represents a 22.52 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CAO Angelo Michael Ninivaggi, Jr. sold 3,113 shares of the business's stock in a transaction on Tuesday, October 29th. The shares were sold at an average price of $144.19, for a total transaction of $448,863.47. Following the completion of the transaction, the chief accounting officer now owns 35,323 shares of the company's stock, valued at approximately $5,093,223.37. This represents a 8.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 32,591 shares of company stock worth $5,143,375. Insiders own 1.76% of the company's stock.

Plexus Company Profile

(Get Free Report)

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.

Recommended Stories

Earnings History and Estimates for Plexus (NASDAQ:PLXS)

Should You Invest $1,000 in Plexus Right Now?

Before you consider Plexus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list.

While Plexus currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines